Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Tropical Medicine and Hygiene|November 27, 2019
Prevalence of <i>Plasmodium</i> spp. in the Amazonian Border Context (French Guiana-Brazil): Associated Factors and Spatial DistributionEmilie Mosnier, Emmanuel Roux, Claire Cropet, et al.
Pediatric Blood & Cancer|August 14, 2013
Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experienceCecile Faure-Conter, Daniel Orbach, Claire Cropet, et al.
The American Journal of Tropical Medicine and Hygiene|July 25, 2018
Epidemiology of Human Leptospirosis in French Guiana (2007-2014): A Retrospective StudyPaul Le Turnier, Emilie Mosnier, Roxane Schaub, et al.
The Lancet. Respiratory Medicine|November 1, 2024
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 studyHervé Léna, Laurent Greillier, Claire Cropet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO studyThomas Bachelot, Céline Bourgier, Claire Cropet, et al.
Journal for Immunotherapy of Cancer|January 8, 2025
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II studyJean-Sébastien Frenel, Laurent Mathiot, Claire Cropet, et al.
The Lancet. Oncology|November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 studyThomas Bachelot, Gilles Romieu, Mario Campone, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patientsJulien Péron, Claire Cropet, Olivier Tredan, et al.
Plos One|February 4, 2017
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.
The Lancet. Oncology|April 13, 2016
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trialOlivier Mir, Claire Cropet, Maud Toulmonde, et al.
Pageof 5